COMPANY PROFILE

Certis Oncology Solutions

Explore full profile

Precision oncology solutions using patient-derived xenograft models for personalized cancer treatment decisions

San Diego, United StatesFounded 2016Biotech & Life Sciences

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Certis Oncology Solutions

Certis Oncology Solutions operates in the precision oncology sector, focusing on personalized cancer treatment through patient-derived xenograft (PDX) models. The company serves patients, oncologists, and pharmaceutical companies by providing clinically relevant models that predict therapeutic response and drug resistance. Certis Oncology's business model revolves around offering advanced cancer research services and innovative cancer treatment solutions. Revenue is generated through service contracts with healthcare providers and pharmaceutical firms, as well as through partnerships in drug development. The company aims to connect every patient to the right therapy for their cancer, the first time, every time, by leveraging cutting-edge oncology research and technology.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: San Diego, United States
Employees: 39
Open positions: None listed
Dealroom signal: 37.9/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES C✓Equity / VC	Jan 2024	$10M	$40M	Undisclosed	↗
SERIES A✓Equity / VC	Jun 2017	$0	—	Undisclosed	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Certis Oncology Solutions website traffic

Latest recorded traffic for Certis Oncology Solutions is 2.8K monthly website visits, down 30% over the last three months. Certis Oncology Solutions's team declined 4.9% over the past year.

Latest monthly visits2.8K 3-month web change-30% 1-year team growth-4.9%

Monthly website visitsNov 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NGNest GenomicsMaking genetic testing mainstream and integrated into patient care is difficult, Â Nest makes it easy	New York City, United States	Operational	17	$11M	$34M
LILinusBioPatient-centric precision exposome medicine, uncovering biomarkers and targets for diseases with historically limited molecular endpoints, spanning CNS, gastroenterology, renal disease, and oncology	North Brunswick Township, United States	Operational
KPKantum PharmaTargeted therapies to prevent and treat damaging inflammation by the innate immune system	Concord, United States	Operational
VBVero BiotechAn emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions	Atlanta, United States	Operational
VEVelentiumMedical Device Products & Lifecycle Management Solutions \| Velentium	Katy, United States	Operational
GBGatehouse BioAccelerating targeted therapies development through deep analysis of small RNAs	Natick, United States	Operational
MPMelt PharmaceuticalsMelt Pharmaceuticals \| Revolutionizing the Surgical Patient Experience	Needham, United States	Acquired
EPELLIPSES PHARMAAccelerating development of promising oncology drug candidates	London, United Kingdom	Operational

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Talent

Book a demo to see the people

Team profiled 5 named & role-tagged

Founders /100 quality score

Key operators 3 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Certis Oncology Solutions on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Certis Oncology Solutions’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.